GSK plc Form 6-K: Report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2025-09-17: Form 6-K; Period of report 2025-09-17; Description TRANSACTION IN OWN SHARES; Document a5920z.htm.
- 2025-09-16: Form 6-K; Period of report 2025-09-16; Description TRANSACTION IN OWN SHARES; Document a4129z.htm.
- 2025-09-15: Form 6-K; Period of report 2025-09-15; Description TRANSACTION IN OWN SHARES; Document a2251z.htm.
- 2025-09-12: Form 6-K; Period of report 2025-09-12; Description TRANSACTION IN OWN SHARES; Document a0432z.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2025-09-17 | 6-K | 2025-09-17 | TRANSACTION IN OWN SHARES | a5920z.htm |
| 2025-09-16 | 6-K | 2025-09-16 | TRANSACTION IN OWN SHARES | a4129z.htm |
| 2025-09-15 | 6-K | 2025-09-15 | TRANSACTION IN OWN SHARES | a2251z.htm |
| 2025-09-12 | 6-K | 2025-09-12 | TRANSACTION IN OWN SHARES | a0432z.htm |
| 2025-09-11 | 6-K | 2025-09-11 | TRANSACTION IN OWN SHARES | a8595y.htm |
| 2025-09-10 | 6-K | 2025-09-10 | DIRECTOR/PDMR SHAREHOLDING | a8372y.htm |
| 2025-09-10 | 6-K | 2025-09-10 | TRANSACTION IN OWN SHARES | a6743y.htm |
| 2025-09-09 | 6-K | 2025-09-09 | TRANSACTION IN OWN SHARES | a4913y.htm |
| 2025-09-08 | 6-K | 2025-09-08 | TRANSACTION IN OWN SHARES | a2946y.htm |
| 2025-09-05 | 6-K | 2025-09-05 | TRANSACTION IN OWN SHARES | a1118y.htm |
| 2025-09-04 | 6-K | 2025-09-04 | DIRECTOR/PDMR SHAREHOLDING | a0502y.htm |
| 2025-09-04 | 6-K | 2025-09-04 | TRANSACTION IN OWN SHARES | a9212x.htm |
| 2025-09-03 | 6-K | 2025-09-03 | TRANSACTION IN OWN SHARES | a7292x.htm |
| 2025-09-02 | 6-K | 2025-09-02 | TRANSACTION IN OWN SHARES | a5467x.htm |
| 2025-09-02 | 6-K | 2025-09-02 | TOTAL VOTING RIGHTS | a5091x.htm |
| 2025-09-02 | 6-K | 2025-09-02 | TRANSACTION IN OWN SHARES | a3339x.htm |
| 2025-08-29 | 6-K | 2025-08-29 | TRANSACTION IN OWN SHARES | a1315x.htm |
| 2025-08-28 | 6-K | 2025-08-28 | TRANSACTION IN OWN SHARES | a9452w.htm |
| 2025-08-27 | 6-K | 2025-08-27 | TRANSACTION IN OWN SHARES | a7568w.htm |
| 2025-08-26 | 6-K | 2025-08-26 | TRANSACTION IN OWN SHARES | a5094w.htm |
| 2025-08-22 | 6-K | 2025-08-22 | TRANSACTION IN OWN SHARES | a3348w.htm |
| 2025-08-21 | 6-K | 2025-08-21 | DIRECTOR/PDMR SHAREHOLDING | a1399w.htm |
| 2025-08-21 | 6-K | 2025-08-21 | TRANSACTION IN OWN SHARES | a1606w.htm |
| 2025-08-20 | 6-K | 2025-08-20 | TRANSACTION IN OWN SHARES | a9790v.htm |
| 2025-08-19 | 6-K | 2025-08-19 | DIRECTOR/PDMR SHAREHOLDING | a9087v.htm |
| 2025-08-19 | 6-K | 2025-08-19 | TRANSACTION IN OWN SHARES | a7948v.htm |
| 2025-08-18 | 6-K | 2025-08-18 | TRANSACTION IN OWN SHARES | a6096v.htm |
| 2025-08-15 | 6-K | 2025-08-15 | TRANSACTION IN OWN SHARES | a4241v.htm |
| 2025-08-14 | 6-K | 2025-08-14 | TRANSACTION IN OWN SHARES | a2473v.htm |
| 2025-08-13 | 6-K | 2025-08-13 | TRANSACTION IN OWN SHARES | a0655v.htm |
| 2025-08-12 | 6-K | 2025-08-12 | DIRECTOR/PDMR SHAREHOLDING | a0094v.htm |
| 2025-08-12 | 6-K | 2025-08-12 | TRANSACTION IN OWN SHARES | a8752u.htm |
| 2025-08-11 | 6-K | 2025-08-11 | FDA TO REVIEW GONORRHEA INDICATION FOR GEPOTIDACIN | a6948u.htm |
| 2025-08-11 | 6-K | 2025-08-11 | TRANSACTION IN OWN SHARES | a6863u.htm |
| 2025-08-08 | 6-K | 2025-08-08 | CUREVAC/BIONTECH MRNA PATENT LITIGATION SETTLEMENT | a5778u.htm |
| 2025-08-08 | 6-K | 2025-08-08 | TRANSACTION IN OWN SHARES | a4942u.htm |
| 2025-08-07 | 6-K | 2025-08-07 | TRANSACTION IN OWN SHARES | a3091u.htm |
| 2025-08-06 | 6-K | 2025-08-06 | TRANSACTION IN OWN SHARES | a1126u.htm |
| 2025-08-05 | 6-K | 2025-08-05 | TRANSACTION IN OWN SHARES | a9185t.htm |
| 2025-08-04 | 6-K | 2025-08-04 | TRANSACTION IN OWN SHARES | a7200t.htm |
| 2025-08-01 | 6-K | 2025-08-01 | TOTAL VOTING RIGHTS | a6617t.htm |
| 2025-08-01 | 6-K | 2025-08-01 | TRANSACTION IN OWN SHARES | a5006t.htm |
| 2025-07-31 | 6-K | 2025-07-31 | TRANSACTION IN OWN SHARES | a2777t.htm |
| 2025-07-30 | 6-K | 2025-07-30 | 2ND QUARTER RESULTS | a0713t-gskplc2ndquarterre.htm |
| 2025-07-30 | 6-K | 2025-07-30 | TRANSACTION IN OWN SHARES | a0774t.htm |
| 2025-07-29 | 6-K | 2025-07-29 | TRANSACTION IN OWN SHARES | a8776s.htm |
| 2025-07-28 | 6-K | 2025-07-28 | GSK ENTERS HENGRUI PHARMA COLLABORATION AGREEMENTS | a7688s.htm |
| 2025-07-28 | 6-K | 2025-07-28 | PRIMARY DOCUMENT | a6905s.htm |
| 2025-07-25 | 6-K | 2025-07-25 | TRANSACTION IN OWN SHARES | a5068s.htm |
| 2025-07-24 | 6-K | 2025-07-24 | BLENREP APPROVED IN THE EU FOR MULTIPLE MYELOMA | a4890s.htm |
| 2025-07-24 | 6-K | 2025-07-24 | TRANSACTION IN OWN SHARES | a3135s.htm |
| 2025-07-23 | 6-K | 2025-07-23 | US FDA REVIEW EXTENDED FOR BLENREP | a2945s.htm |
| 2025-07-23 | 6-K | 2025-07-23 | TRANSACTION IN OWN SHARES | a1314s.htm |
| 2025-07-22 | 6-K | 2025-07-22 | TRANSACTION IN OWN SHARES | a9452r.htm |
| 2025-07-21 | 6-K | 2025-07-21 | TRANSACTION IN OWN SHARES | a7520r.htm |
| 2025-07-18 | 6-K | 2025-07-18 | DIRECTOR/PDMR SHAREHOLDING | a7225r.htm |
| 2025-07-18 | 6-K | 2025-07-18 | BLENREP US ODAC OUTCOME | a5747r.htm |
| 2025-07-18 | 6-K | 2025-07-18 | TRANSACTION IN OWN SHARES | a5693r.htm |
| 2025-07-17 | 6-K | 2025-07-17 | GSKS SHINGRIX FULLY LIQUID FDA APPROVAL | a3837r.htm |
| 2025-07-17 | 6-K | 2025-07-17 | TRANSACTION IN OWN SHARES | a3808r.htm |
| 2025-07-16 | 6-K | 2025-07-16 | TRANSACTION IN OWN SHARES | a1942r.htm |
| 2025-07-15 | 6-K | 2025-07-15 | DIRECTOR/PDMR SHAREHOLDING | a1680r.htm |
| 2025-07-15 | 6-K | 2025-07-15 | TRANSACTION IN OWN SHARES | a0087r.htm |
| 2025-07-14 | 6-K | 2025-07-14 | DIRECTOR/PDMR SHAREHOLDING | a9873q.htm |
| 2025-07-14 | 6-K | 2025-07-14 | GSK SUBMITS AREXVY FOR ADULTS 18-49 AIR TO FDA | a8989q.htm |
| 2025-07-14 | 6-K | 2025-07-14 | TRANSACTION IN OWN SHARES | a8168q.htm |
| 2025-07-11 | 6-K | 2025-07-11 | TRANSACTION IN OWN SHARES | a6377q.htm |
| 2025-07-10 | 6-K | 2025-07-10 | TRANSACTION IN OWN SHARES | a4398q.htm |
| 2025-07-09 | 6-K | 2025-07-09 | TRANSACTION IN OWN SHARES | a2489q.htm |
| 2025-07-08 | 6-K | 2025-07-08 | TRANSACTION IN OWN SHARES | a0650q.htm |
| 2025-07-07 | 6-K | 2025-07-07 | GSK COMPLETES ACQUISITION OF EFIMOSFERMIN FOR SLD | a0292q.htm |
| 2025-07-07 | 6-K | 2025-07-07 | TRANSACTION IN OWN SHARES | a8861p.htm |
| 2025-07-07 | 6-K | 2025-07-07 | TRANSACTION IN OWN SHARES | a6948p.htm |
| 2025-07-03 | 6-K | 2025-07-03 | TRANSACTION IN OWN SHARES | a5019p.htm |
| 2025-07-02 | 6-K | 2025-07-02 | TRANSACTION IN OWN SHARES | a2992p.htm |
| 2025-07-01 | 6-K | 2025-07-01 | TOTAL VOTING RIGHTS | a2441p.htm |
| 2025-07-01 | 6-K | 2025-07-01 | TRANSACTION IN OWN SHARES | a0751p.htm |
| 2025-06-30 | 6-K | 2025-06-30 | TRANSACTION IN OWN SHARES | a8478o.htm |
| 2025-06-27 | 6-K | 2025-06-27 | TRANSACTION IN OWN SHARES | a6466o.htm |
| 2025-06-26 | 6-K | 2025-06-26 | TRANSACTION IN OWN SHARES | a4469o.htm |
| 2025-06-25 | 6-K | 2025-06-25 | TRANSACTION IN OWN SHARES | a2563o.htm |
| 2025-06-24 | 6-K | 2025-06-24 | DIRECTOR/PDMR SHAREHOLDING | a2217o-ppcb4535b3.htm |
| 2025-06-24 | 6-K | 2025-06-24 | DIRECTOR DECLARATION | a2179o.htm |
| 2025-06-24 | 6-K | 2025-06-24 | TRANSACTION IN OWN SHARES | a0609o.htm |
| 2025-06-23 | 6-K | 2025-06-23 | DIRECTOR/PDMR SHAREHOLDING | a0563o.htm |
| 2025-06-23 | 6-K | 2025-06-23 | LINERIXIBAT FILE ACCEPTED BY EMA | a9467n-1.htm |
| 2025-06-23 | 6-K | 2025-06-23 | TRANSACTION IN OWN SHARES | a8550n.htm |
| 2025-06-20 | 6-K | 2025-06-20 | AREXVY FILED IN JAPAN FOR 18-49 AT INCREASED RISK | a6664n.htm |
| 2025-06-20 | 6-K | 2025-06-20 | TRANSACTION IN OWN SHARES | a6605n.htm |
| 2025-06-20 | 6-K | 2025-06-20 | TRANSACTION IN OWN SHARES | a4688n.htm |
| 2025-06-18 | 6-K | 2025-06-18 | TRANSACTION IN OWN SHARES | a2651n.htm |
| 2025-06-17 | 6-K | 2025-06-17 | TRANSACTION IN OWN SHARES | a0687n.htm |
| 2025-06-16 | 6-K | 2025-06-16 | TRANSACTION IN OWN SHARES | a8704m.htm |
| 2025-06-13 | 6-K | 2025-06-13 | DIRECTOR/PDMR SHAREHOLDING | a8469m.htm |
| 2025-06-13 | 6-K | 2025-06-13 | TRANSACTION IN OWN SHARES | a6755m.htm |
| 2025-06-13 | 6-K | 2025-06-13 | GSK SUBMITS AREXVY FOR ADULTS 18+ WITH EMA | a6382m.htm |
| 2025-06-12 | 6-K | 2025-06-12 | DIRECTOR/PDMR SHAREHOLDING | a6049m.htm |
| 2025-06-12 | 6-K | 2025-06-12 | TRANSACTION IN OWN SHARES | a4796m.htm |
| 2025-06-11 | 6-K | 2025-06-11 | DIRECTOR/PDMR SHAREHOLDING | a2664m.htm |
| 2025-06-11 | 6-K | 2025-06-11 | TRANSACTION IN OWN SHARES | a2842m.htm |